[Pituitary disease: which treatment in the future?]

C Briet; P Chanson

doi:10.1016/S0003-4266(11)70003-8

[Pituitary disease: which treatment in the future?]

Ann Endocrinol (Paris). 2011 Oct:72 Suppl 1:S2-7. doi: 10.1016/S0003-4266(11)70003-8.

[Article in French]

Authors

C Briet¹, P Chanson

Affiliation

¹ INSERM U 986, Hôpital Saint-Vincent-de-Paul, 82 avenue Denfert-Rochereau, Paris, France.

PMID: 22008273
DOI: 10.1016/S0003-4266(11)70003-8

Abstract

Even if major progress has been made in the medical treatment for pituitary adenomas in the last decades, currently available drugs do not always control hormonal secretion of these tumors. New molecules or new formulations of old drugs are under development. Pituitary stem cells research is currently also very active.

Publication types

English Abstract

MeSH terms

Adenoma / drug therapy*
Adult Stem Cells / drug effects
Animals
Antineoplastic Agents / therapeutic use*
Clinical Trials as Topic
Humans
Pituitary ACTH Hypersecretion / drug therapy
Pituitary Neoplasms / drug therapy*
Rats
SOXB1 Transcription Factors / metabolism
Treatment Outcome

Substances

Antineoplastic Agents
SOX2 protein, human
SOXB1 Transcription Factors
Sox2 protein, rat